
Immusant, Inc.
Get Full AccessDescription
- ImmusanT is a privately held biotechnology company focused on protecting patients with celiac disease against the effects of gluten. By harnessing new discoveries in immunology ImmusanT aims to improve diagnosis and medical management of celiac disease byprotecting against the effects of gluten exposure while patients maintain a gluten free diet. The company is developing Nexvax2®, a therapeutic vaccine for celiac disease, and diagnostic and monitoring tools to improve celiac disease management. ImmusanTs targeted immunotherapy discovery platform can be applied to a variety of autoimmune diseases. Founded in 2010, ImmusanT is backed by Vatera Healthcare Partners. More information may be found at www.ImmusanT.com, or follow @ImmusanT on Twitter.
-
Headquarters:1 Kendall Square , Cambridge, Massachusetts, United States
More -
Phone Number: +1 617-299-8399
-
Website: https://www.immusant.com
-
Employees:8
-
Revenue:$1 - 10M
-
Legal Name:Immusant, Inc.
-
Immusant, Inc.'s Social Media
-
Is this data correct?
-
| NAICS Code: 541714 |
Show More
Frequently Asked Questions regarding Immusant, Inc.
-
Where are Immusant, Inc.'s Headquarters?
Immusant, Inc.'s Headquarters are in 1 Kendall Square ,Cambridge,Massachusetts,United States
-
What is Immusant, Inc.'s phone number?
Immusant, Inc.'s phone number is +1 617-299-8399
-
What is Immusant, Inc.'s official website?
Immusant, Inc.'s official website is https://www.immusant.com
-
What is Immusant, Inc.'s Revenue?
Immusant, Inc.'s revenue is $1 - 10M
-
What is Immusant, Inc.'s NAICS code?
Immusant, Inc.'s NAICS code is 541714
-
How many employees are working in Immusant, Inc.
Immusant, Inc. has 8 employees
-
What is Immusant, Inc.'s Industry?
Immusant, Inc. is in the industry of Biotechnology
-
Who is Immusant, Inc.'s Director Of Assay Development?
Immusant, Inc.'s Director Of Assay Development is Suyue Wang